Epidemiological data on cervical carcinoma relevant to cytopathology

Epidemiological studies based on cervical cytopathology have aroused widespread interest since it was realized that they could be a useful tool for measuring the effectiveness of screening programs and defining practical measures for the prevention of invasive neoplasms and deaths. In the present ar...

Full description

Bibliographic Details
Main Authors: C. La Vecchia, A. Decarli, G. Gallus
Format: Article in Journal/Newspaper
Language:English
Published: 1987
Subjects:
Online Access:http://hdl.handle.net/2434/186086
_version_ 1821555943693877248
author C. La Vecchia
A. Decarli
G. Gallus
author2 C. La Vecchia
A. Decarli
G. Gallus
author_facet C. La Vecchia
A. Decarli
G. Gallus
author_sort C. La Vecchia
collection The University of Milan: Archivio Istituzionale della Ricerca (AIR)
description Epidemiological studies based on cervical cytopathology have aroused widespread interest since it was realized that they could be a useful tool for measuring the effectiveness of screening programs and defining practical measures for the prevention of invasive neoplasms and deaths. In the present article, published evidence from screening programs, cohort investigations and case-control studies is reviewed, and possibilities for further analyses and applications are discussed. In particular, when estimates of the relative protections conveyed by Pap smear from various case-control studies conducted on different populations and using different criteria of selection were pooled, a surprisingly close concordance emerged, with overall risk estimates of invasive cervical cancer of 0.42 for women reporting one smear, and of 0.20 for two or more smears in the past. This protection appeared to be long-lasting in a considerable proportion of cases, since the major determinant of invasive cancer risk was the number of previous smears rather than the interval since last smear, and a noticeable residual effect was evident even more than 10 years after the last smear. Besides providing a measure of the effectiveness of cytological screening and helping define the optimal frequency of screening using the limited resources available, case-control studies should permit accurate estimates of the sensitivity of the test and quantify the probability of transition and the duration of various stages of the neoplastic process, i.e., permit a better understanding of the natural history of the disease.
format Article in Journal/Newspaper
genre Iceland
genre_facet Iceland
geographic Norway
geographic_facet Norway
id ftunivmilanoair:oai:air.unimi.it:2434/186086
institution Open Polar
language English
op_collection_id ftunivmilanoair
op_relation info:eu-repo/semantics/altIdentifier/pmid/3620205
volume:5
issue:1
firstpage:25
lastpage:32
journal:APPLIED PATHOLOGY
http://hdl.handle.net/2434/186086
info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-0023276889
publishDate 1987
record_format openpolar
spelling ftunivmilanoair:oai:air.unimi.it:2434/186086 2025-01-16T22:39:15+00:00 Epidemiological data on cervical carcinoma relevant to cytopathology C. La Vecchia A. Decarli G. Gallus C. La Vecchia A. Decarli G. Gallus 1987 http://hdl.handle.net/2434/186086 eng eng info:eu-repo/semantics/altIdentifier/pmid/3620205 volume:5 issue:1 firstpage:25 lastpage:32 journal:APPLIED PATHOLOGY http://hdl.handle.net/2434/186086 info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-0023276889 Uterine Cervical Neoplasm Genital Diseases Female Risk Mass Screening Human Denmark Norway Iceland Italy Carcinoma Settore MED/01 - Statistica Medica info:eu-repo/semantics/article 1987 ftunivmilanoair 2024-03-27T16:31:57Z Epidemiological studies based on cervical cytopathology have aroused widespread interest since it was realized that they could be a useful tool for measuring the effectiveness of screening programs and defining practical measures for the prevention of invasive neoplasms and deaths. In the present article, published evidence from screening programs, cohort investigations and case-control studies is reviewed, and possibilities for further analyses and applications are discussed. In particular, when estimates of the relative protections conveyed by Pap smear from various case-control studies conducted on different populations and using different criteria of selection were pooled, a surprisingly close concordance emerged, with overall risk estimates of invasive cervical cancer of 0.42 for women reporting one smear, and of 0.20 for two or more smears in the past. This protection appeared to be long-lasting in a considerable proportion of cases, since the major determinant of invasive cancer risk was the number of previous smears rather than the interval since last smear, and a noticeable residual effect was evident even more than 10 years after the last smear. Besides providing a measure of the effectiveness of cytological screening and helping define the optimal frequency of screening using the limited resources available, case-control studies should permit accurate estimates of the sensitivity of the test and quantify the probability of transition and the duration of various stages of the neoplastic process, i.e., permit a better understanding of the natural history of the disease. Article in Journal/Newspaper Iceland The University of Milan: Archivio Istituzionale della Ricerca (AIR) Norway
spellingShingle Uterine Cervical Neoplasm
Genital Diseases
Female
Risk
Mass Screening
Human
Denmark
Norway
Iceland
Italy
Carcinoma
Settore MED/01 - Statistica Medica
C. La Vecchia
A. Decarli
G. Gallus
Epidemiological data on cervical carcinoma relevant to cytopathology
title Epidemiological data on cervical carcinoma relevant to cytopathology
title_full Epidemiological data on cervical carcinoma relevant to cytopathology
title_fullStr Epidemiological data on cervical carcinoma relevant to cytopathology
title_full_unstemmed Epidemiological data on cervical carcinoma relevant to cytopathology
title_short Epidemiological data on cervical carcinoma relevant to cytopathology
title_sort epidemiological data on cervical carcinoma relevant to cytopathology
topic Uterine Cervical Neoplasm
Genital Diseases
Female
Risk
Mass Screening
Human
Denmark
Norway
Iceland
Italy
Carcinoma
Settore MED/01 - Statistica Medica
topic_facet Uterine Cervical Neoplasm
Genital Diseases
Female
Risk
Mass Screening
Human
Denmark
Norway
Iceland
Italy
Carcinoma
Settore MED/01 - Statistica Medica
url http://hdl.handle.net/2434/186086